MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
150 hedge funds and large institutions have $931M invested in Merrimack Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 66 increasing their positions, 34 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 19
1% less funds holding
Funds holding: 152 → 150 (-2)
Holders
150
Holding in Top 10
1
Calls
$6.62M
Puts
$2.61M
Top Buyers
| 1 | +$24.5M | |
| 2 | +$8.83M | |
| 3 | +$8.31M | |
| 4 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$6.55M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$6.5M |
Top Sellers
| 1 | -$7.83M | |
| 2 | -$4.13M | |
| 3 | -$3.17M | |
| 4 |
SIM
Spark Investment Management
New York
|
-$2.64M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.88M |